Here are four takeaways:
1. Prohesion is an activated type I collagen wound filler indicated for surgical wound management.
2. The technology is patented and uses type I collagen fragments that have been sheared down to an optimal size.
3. It is in a powder format that allows for complete and liberal coverage of surgical wounds.
4. BioStructures is focused on developing proprietary platforms in bioresorbable bone graft products for a number of spinal and orthopedic fusion procedures.
More articles on devices:
5 things to know about ApiFix’s new board chairman Ted Bird
Mazor appoints Chad Zaring vice president of national accounts — 5 key notes
SpineGuard launches public offering, buoys growth strategy — 8 things to know
